HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

16.830

-0.030-0.18%

Volume:1.08M

Turnover:18.02M

Market Cap:17.86B

PE:-56.01

High:16.910

Open:16.150

Low:16.150

Close:16.860

52wk High:18.750

52wk Low:4.090

Shares:1.06B

HK Float Shares:1.06B

Volume Ratio:0.30

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.300

ROE:-12.77%

ROA:-12.32%

PB:8.44

PE(LYR):-56.01

PS:6669.54

Loading ...

Overview Company News Filings

Ascletis Pharma Seeks HK$843 Million via Share Offering

MT Newswires Live

BRIEF-Ascletis Pharma To Place 69.3 Million Shares

ASCLETIS-B (01672) Proposes Placement of 69.256 Million Shares at Approximately 4% Discount, Targeting Net Proceeds of About HK$835.3 Million

Ascletis Pharma kündigt Privatplatzierung neuer Aktien an

Ascletis Pharma Inc - to Place 69.3 Mln Shares at HK$12.18 per Share

THOMSON REUTERS

Sagimet Biosciences Reports Positive 52-Week Phase 3 Results for Denifanstat in Moderate to Severe Acne

Assessing Ascletis Pharma (SEHK:1672) Valuation After Positive Acne Data And Denifanstat NDA Acceptance

Simply Wall St.

BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of Denifanstat

Ascletis Pharma Inc. (1672) Announces Positive Phase III Data on Denifanstat (ASC40) for Acne Treatment

Bulletin Express

Ascletis Pharma-B (01672): First-in-Class Oral FASN Inhibitor Denifostat (ASC40) Achieves Positive Topline Results in Phase III Open-Label Acne Study

Ascletis Announces Positive Topline Results From Its Phase Iii Open-Label Study of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne

THOMSON REUTERS

Ascletis Pharma Inc - Denifanstat (Asc40) Shows Favorable Safety in Phase Iii Study

THOMSON REUTERS

Ascletis Pharma New Drug Application for Denifanstat Accepted by China National Medical Products Administration

Ascletis Pharma Inc - Positive Topline Results From Phase Iii Open-Label Study of Denifanstat (Asc40)

THOMSON REUTERS

Hong Kong Stocks Movement | Ascletis Pharma-B (01672) Rises Over 4% in Afternoon Trading as Company Initiates Patient Dosing for Diabetes Drug ASC30 Phase II Trial

ASCLETIS-B (01672) Announces Completion of First Dosing in 13-Week US Phase II Study of Oral Small-Molecule GLP-1R Agonist ASC30 for Diabetes

Ascletis Announces First Participants Dosed in a 13-Week U.S. Phase Ii Study With Asc30, an Oral Small Molecule Glp-1R Agonist for the Treatment of Diabetes

THOMSON REUTERS

Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC37 Next Generation Cardio Metabolic Update

Simply Wall St.

ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development

Ascletis Unveils Potent Once-Monthly Triple Agonist ASC37 for Obesity Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01672/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":16.83,"timestamp":1774858100003,"preClose":16.86,"halted":0,"volume":1082693,"delay":0,"changeRate":-0.0017793594306050498,"floatShares":1061000000,"shares":1061000000,"eps":-0.300458,"marketStatus":"Not Yet Opened","change":-0.03,"latestTime":"03-30 16:08:20","open":16.15,"high":16.91,"low":16.15,"amount":18019605,"amplitude":0.045077,"askPrice":16.92,"askSize":5000,"bidPrice":16.83,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.267,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774920600000},"marketStatusCode":0,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":16.86,"openAndCloseTimeList":[[1774834200000,1774843200000],[1774846800000,1774857600000]],"volumeRatio":0.29805747417166384,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":1061000000,"roa":"-12.32%","roe":"-12.77%","lyrEps":-0.300458,"volumeRatio":0.29805747417166384,"shares":1061000000,"dividePrice":0,"high":16.91,"amplitude":0.045077,"preClose":16.86,"low":16.15,"week52Low":4.09,"pbRate":"8.44","psRate":"6669.54","week52High":18.75,"institutionHeld":0,"latestPrice":16.83,"committee":-0.666667,"eps":-0.300458,"divideRate":0,"volume":1082693,"delay":0,"ttmEps":-0.267,"open":16.15,"prevYearClose":11.39,"prevWeekClose":16.86,"prevMonthClose":15.76,"prevQuarterClose":11.39,"fiveDayClose":13.11,"twentyDayClose":15.26,"sixtyDayClose":11.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-15","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755221400000,"name":null,"time":"","dateTimestamp":1755187200000,"actualEps":null},{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-25","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1750003200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2026-03-27","current":-63.033708,"percent":0.002441,"low":-64.074951,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"high":-3.060869,"avg":-17.051783,"sd":12.925077,"marketCap":17890657195},"quantilePoints":[{"date":"2021-04-01","current":-12.856888,"twenty":-27.937324,"median":-26.841361,"eighty":-25.906193,"marketCap":3186467800},{"date":"2021-04-09","current":-12.651626,"twenty":-27.902405,"median":-26.79135,"eighty":-25.749374,"marketCap":3142516520},{"date":"2021-04-16","current":-12.515766,"twenty":-27.83964,"median":-26.703111,"eighty":-25.606579,"marketCap":3120540880},{"date":"2021-04-23","current":-12.748275,"twenty":-27.761167,"median":-26.610487,"eighty":-20.3699,"marketCap":3186467800},{"date":"2021-04-30","current":-12.958615,"twenty":-27.702929,"median":-26.546385,"eighty":-12.849963,"marketCap":3252394720},{"date":"2021-05-07","current":-13.875629,"twenty":-27.671533,"median":-26.500215,"eighty":-12.917924,"marketCap":3505114580},{"date":"2021-05-14","current":-13.623513,"twenty":-27.632266,"median":-26.264893,"eighty":-13.033167,"marketCap":3439187660},{"date":"2021-05-21","current":-13.663274,"twenty":-27.599178,"median":-26.114327,"eighty":-13.140261,"marketCap":3450175480},{"date":"2021-05-28","current":-15.770587,"twenty":-27.536493,"median":-26.046286,"eighty":-13.276483,"marketCap":4021542120},{"date":"2021-06-04","current":-14.720056,"twenty":-27.44752,"median":-25.775671,"eighty":-13.355805,"marketCap":3735858800},{"date":"2021-06-11","current":-16.063352,"twenty":-27.383939,"median":-25.742295,"eighty":-13.363408,"marketCap":4076481220},{"date":"2021-06-18","current":-14.31767,"twenty":-27.321052,"median":-25.623114,"eighty":-13.37885,"marketCap":3604004960},{"date":"2021-06-25","current":-15.287624,"twenty":-27.213321,"median":-25.50862,"eighty":-13.470373,"marketCap":3845737000},{"date":"2021-07-02","current":-15.35814,"twenty":-27.20728,"median":-21.095972,"eighty":-13.623513,"marketCap":3856724820},{"date":"2021-07-09","current":-15.855335,"twenty":-27.138398,"median":-16.377335,"eighty":-13.663274,"marketCap":3977590840},{"date":"2021-07-16","current":-14.892058,"twenty":-27.096973,"median":-16.253526,"eighty":-13.686225,"marketCap":3735858800},{"date":"2021-07-23","current":-14.192621,"twenty":-26.97726,"median":-16.035624,"eighty":-13.755247,"marketCap":3560053680},{"date":"2021-07-30","current":-12.791706,"twenty":-26.94677,"median":-15.809995,"eighty":-13.432088,"marketCap":3219431260},{"date":"2021-08-06","current":-12.341273,"twenty":-26.946171,"median":-15.662682,"eighty":-13.226349,"marketCap":3098565240},{"date":"2021-08-13","current":-12.368185,"twenty":-26.904217,"median":-15.576148,"eighty":-12.99939,"marketCap":3109553060},{"date":"2021-08-20","current":-11.921226,"twenty":-26.880965,"median":-15.419458,"eighty":-12.856888,"marketCap":2988687040},{"date":"2021-08-27","current":-9.483763,"twenty":-26.801757,"median":-15.385644,"eighty":-12.791706,"marketCap":3065601780},{"date":"2021-09-03","current":-9.989583,"twenty":-26.79135,"median":-15.321348,"eighty":-12.740344,"marketCap":3230419080},{"date":"2021-09-10","current":-10.099521,"twenty":-26.758891,"median":-15.242013,"eighty":-12.683051,"marketCap":3274370360},{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500},{"date":"2025-04-11","current":-16.143826,"twenty":-25.799935,"median":-13.637196,"eighty":-7.037853,"marketCap":5154695920},{"date":"2025-04-17","current":-14.844692,"twenty":-25.761244,"median":-13.643555,"eighty":-7.040226,"marketCap":4751255705},{"date":"2025-04-25","current":-18.855479,"twenty":-25.629177,"median":-13.630838,"eighty":-7.035481,"marketCap":6040177180},{"date":"2025-05-02","current":-19.624433,"twenty":-25.555188,"median":-13.637196,"eighty":-7.037853,"marketCap":6299866327},{"date":"2025-05-09","current":-19.687295,"twenty":-25.378575,"median":-13.630838,"eighty":-7.035481,"marketCap":6364413943},{"date":"2025-05-16","current":-16.189425,"twenty":-25.028984,"median":-13.630838,"eighty":-7.035481,"marketCap":5276397641},{"date":"2025-05-23","current":-19.381154,"twenty":-24.642413,"median":-13.630838,"eighty":-7.035481,"marketCap":6335528555},{"date":"2025-05-30","current":-22.492822,"twenty":-24.315979,"median":-13.630838,"eighty":-7.035481,"marketCap":7385031005},{"date":"2025-06-06","current":-22.37708,"twenty":-24.163622,"median":-13.630838,"eighty":-7.035481,"marketCap":7365774080},{"date":"2025-06-13","current":-27.602111,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9089268930},{"date":"2025-06-20","current":-28.183664,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9262581261},{"date":"2025-06-27","current":-25.15423,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8290106513},{"date":"2025-07-04","current":-27.519363,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9070012004},{"date":"2025-07-11","current":-25.909492,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8530818085},{"date":"2025-07-18","current":-34.00727,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11188273831},{"date":"2025-07-25","current":-31.259636,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10321712175},{"date":"2025-08-01","current":-30.808479,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10109885992},{"date":"2025-08-08","current":-40.038892,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13171737178},{"date":"2025-08-15","current":-51.999696,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17080893095},{"date":"2025-08-22","current":-50.820081,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14298267332},{"date":"2025-08-29","current":-48.026994,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13576938778},{"date":"2025-09-05","current":-47.125793,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13308972881},{"date":"2025-09-12","current":-39.078151,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11056074414},{"date":"2025-09-19","current":-37.494834,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10600591060},{"date":"2025-09-26","current":-36.39561,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10263119060},{"date":"2025-10-03","current":-37.842129,"twenty":-24.207039,"median":-13.643555,"eighty":-7.040226,"marketCap":10696487426},{"date":"2025-10-10","current":-33.495493,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9454067526},{"date":"2025-10-17","current":-32.00426,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9026136568},{"date":"2025-10-24","current":-32.086576,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9052642598},{"date":"2025-10-31","current":-33.892495,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9576412188},{"date":"2025-11-07","current":-33.200765,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9375102324},{"date":"2025-11-14","current":-48.131606,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13629727156},{"date":"2025-11-21","current":-46.471802,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13153579483},{"date":"2025-11-28","current":-51.08762,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14512584301},{"date":"2025-12-05","current":-47.583674,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13540449468},{"date":"2025-12-12","current":-50.523029,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14403467126},{"date":"2025-12-19","current":-45.12776,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12895666160},{"date":"2025-12-24","current":-43.638002,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12508796175},{"date":"2026-01-02","current":-39.705675,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":11426392166},{"date":"2026-01-09","current":-43.068244,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":12424923948},{"date":"2026-01-16","current":-45.622443,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13204565721},{"date":"2026-01-23","current":-48.737975,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":14092765209},{"date":"2026-01-30","current":-46.885388,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13619058816},{"date":"2026-02-06","current":-51.771469,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":15076489664},{"date":"2026-02-13","current":-59.490106,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17423759854},{"date":"2026-02-20","current":-64.074951,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":18739561451},{"date":"2026-02-27","current":-56.560964,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":16723413843},{"date":"2026-03-06","current":-52.10008,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15280276608},{"date":"2026-03-13","current":-53.661958,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15810841768},{"date":"2026-03-20","current":-51.190704,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15025605331},{"date":"2026-03-27","current":-61.10711,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":17890657195}],"updateTime":1774902838734},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608123118","title":"Ascletis Pharma Seeks HK$843 Million via Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2608123118","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608123118?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:20","pubTimestamp":1770081645,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it was looking to raise HK$843.5 million via a share offering, according to a Hong Kong bourse filing Tuesday.The firm is seeking investors for around 69.3 million shares priced at HK$12.18 apiece to raise funds for the global phase 3 trials of its ASC30 drug for the treatment of obesity.The shares represent 6.98% of the company's issued share capital.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01672","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2608812836","title":"BRIEF-Ascletis Pharma To Place 69.3 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2608812836","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608812836?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:19","pubTimestamp":1770081598,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma To Place 69.3 Million SharesFeb 3 (Reuters) - Ascletis Pharma Inc 1672.HK:TO PLACE 69.3 MILLION SHARES AT HK$12.18 PER SHAREFurther company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YY0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"1194027137","title":"ASCLETIS-B (01672) Proposes Placement of 69.256 Million Shares at Approximately 4% Discount, Targeting Net Proceeds of About HK$835.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1194027137","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194027137?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:44","pubTimestamp":1770075857,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that on February 3, 2026, the company proposes to place 69.256 million shares, representing approximately 6.98% of the company's issued share capital as of the date of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK1161","BK1574","01477","01672"],"gpt_icon":0},{"id":"2608816721","title":"Ascletis Pharma kündigt Privatplatzierung neuer Aktien an","url":"https://stock-news.laohu8.com/highlight/detail?id=2608816721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608816721?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:41","pubTimestamp":1770075710,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLNPmZt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2608164468","title":"Ascletis Pharma Inc -  to Place 69.3 Mln Shares at HK$12.18 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608164468","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608164468?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:31","pubTimestamp":1770075105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1574","BK1161","01672"],"gpt_icon":0},{"id":"2608657558","title":"Sagimet Biosciences Reports Positive 52-Week Phase 3 Results for Denifanstat in Moderate to Severe Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2608657558","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608657558?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:00","pubTimestamp":1770033629,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. announced positive 52-week data from an open-label Phase 3 clinical trial conducted by its license partner, Ascletis Pharma Inc., evaluating the long-term safety of ASC40  tablets in patients with moderate to severe acne. The topline results from this trial were reported in a press release issued by Ascletis on January 29. Denifanstat is an oral fatty acid synthase  inhibitor developed by Ascletis for acne in China and by Sagimet for MASH in other regions. In June 2025, Ascletis also reported that denifanstat met all primary, key secondary, and secondary endpoints in a separate 480-patient randomized, double-blind, placebo-controlled Phase 3 trial for moderate to severe acne vulgaris. Results from both studies have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLc00t16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","SGMT","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","01672","BK1574","SG9999014005.SGD","BK1515","BK4112","LU2210149790.SGD"],"gpt_icon":0},{"id":"2608837837","title":"Assessing Ascletis Pharma (SEHK:1672) Valuation After Positive Acne Data And Denifanstat NDA Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=2608837837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608837837?lang=en_us&edition=fundamental","pubTime":"2026-02-02 10:11","pubTimestamp":1769998295,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) is back in focus after reporting favorable long term safety data from its Phase III acne drug denifanstat and confirming that China’s regulator has accepted its New Drug Application.\nSee our latest analysis for Ascletis Pharma.\nThe acne data and NDA progress come on the back of an active few weeks across its GLP 1 and metabolic pipeline. The share price has moved accordingly, with a 30 day share price return of 19.79% and 90 day share price return of 40.67%, adding...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-positive","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-positive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2607386890","title":"BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of Denifanstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2607386890","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607386890?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:46","pubTimestamp":1769694367,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of DenifanstatJan 29 (Reuters) - Ascletis Pharma Inc 1672.HK:POSITIVE TOPLINE RESULTS FROM PHASE III OPEN-LABEL STUDY OF DENIFANSTAT (ASC40)Further company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU04P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"1151778806","title":"Ascletis Pharma Inc. (1672) Announces Positive Phase III Data on Denifanstat (ASC40) for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1151778806","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151778806?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:05","pubTimestamp":1769684706,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. (1672) released topline results from a Phase III open-label trial (NCT06248008) evaluating denifanstat (ASC40) in 240 patients with moderate to severe acne vulgaris. The study,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"1105812294","title":"Ascletis Pharma-B (01672): First-in-Class Oral FASN Inhibitor Denifostat (ASC40) Achieves Positive Topline Results in Phase III Open-Label Acne Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1105812294","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105812294?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684431,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) announced positive topline results from a Phase III open-label study (NCT06248008) of denifostat (ASC40), a first-in-class, once-daily oral small-molecule fatty acid...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK1161","BK1191","BK1515","01477","BK4134","01672","BK1574"],"gpt_icon":0},{"id":"2607858060","title":"Ascletis Announces Positive Topline Results From Its Phase Iii Open-Label Study of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2607858060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607858060?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUAC0NCDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","01672","BK1515"],"gpt_icon":0},{"id":"2607085809","title":"Ascletis Pharma Inc - Denifanstat (Asc40) Shows Favorable Safety in Phase Iii Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2607085809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607085809?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUAC0NCDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2607832600","title":"Ascletis Pharma New Drug Application for Denifanstat Accepted by China National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2607832600","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607832600?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:51","pubTimestamp":1769683870,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. announced that its New Drug Application  for denifanstat , a first-in-class, once-daily oral fatty acid synthase  inhibitor for the treatment of moderate-to-severe acne vulgaris, was recently accepted by the China National Medical Products Administration. The acceptance follows positive topline results from two Phase III studies, including a recently completed open-label multicenter study in China evaluating the long-term safety of denifanstat in 240 patients. Denifanstat  is licensed from Sagimet Biosciences Inc. for exclusive rights in Greater China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL1NxTbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","01672","BK1161","BK1574","SGMT","BK1515"],"gpt_icon":0},{"id":"2607708347","title":"Ascletis Pharma Inc - Positive Topline Results From Phase Iii Open-Label Study of Denifanstat (Asc40)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607708347?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:50","pubTimestamp":1769683851,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU04P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"1182057967","title":"Hong Kong Stocks Movement | Ascletis Pharma-B (01672) Rises Over 4% in Afternoon Trading as Company Initiates Patient Dosing for Diabetes Drug ASC30 Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1182057967","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182057967?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:28","pubTimestamp":1769668113,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) saw its shares climb more than 4% in afternoon trading. At the time of writing, the stock was up 3.85%, trading at HK$13.76, with a turnover of HK$12.1855 million. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","01672","VT","BK1515","BK4585","BK4588","BK1161","BK1574"],"gpt_icon":0},{"id":"1115934877","title":"ASCLETIS-B (01672) Announces Completion of First Dosing in 13-Week US Phase II Study of Oral Small-Molecule GLP-1R Agonist ASC30 for Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1115934877","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115934877?lang=en_us&edition=fundamental","pubTime":"2026-01-26 08:26","pubTimestamp":1769387173,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that its Board of Directors declared the completion of the first patient dosing in a 13-week US Phase II study (NCT07321678) of its oral small-molecule GLP-1 receptor...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","BK1161","01672","GLP","BK1574","BK4590","01477","BK4144"],"gpt_icon":0},{"id":"2606261145","title":"Ascletis Announces First Participants Dosed in a 13-Week U.S. Phase Ii Study With Asc30, an Oral Small Molecule Glp-1R Agonist for the Treatment of Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2606261145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606261145?lang=en_us&edition=fundamental","pubTime":"2026-01-26 08:10","pubTimestamp":1769386200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUA73JRLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"2606923014","title":"Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC37 Next Generation Cardio Metabolic Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2606923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606923014?lang=en_us&edition=fundamental","pubTime":"2026-01-25 02:34","pubTimestamp":1769279678,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) has attracted fresh attention after announcing ASC37, a once-monthly subcutaneous GLP-1R/GIPR/GCGR triple agonist for cardiometabolic diseases, discovered using its AI assisted and ultra long acting peptide platforms.\nSee our latest analysis for Ascletis Pharma.\nThe ASC37 announcement lands after a strong run in the shares, with a 90 day share price return of 56.58% and a year to date share price return of 23.96%. The 1 year total shareholder return of 249.14%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-asc37-nex","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-asc37-nex","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","01672","BK1161","BK1574"],"gpt_icon":0},{"id":"1158406293","title":"ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1158406293","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158406293?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:56","pubTimestamp":1768903007,"startTime":"0","endTime":"0","summary":"The Board of ASCLETIS-B (01672) announced that it has selected ASC37, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR triple agonist peptide, as a clinical development...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574","BK4144","BK4590","GLP","GIPR","01672","BK1515","BK4160","BK1161"],"gpt_icon":0},{"id":"2604317195","title":"Ascletis Unveils Potent Once-Monthly Triple Agonist ASC37 for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2604317195","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604317195?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:00","pubTimestamp":1768899651,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced the selection of ASC37 injection, a next-generation GLP-1R/GIPR/GCGR triple peptide agonist, as a clinical development candidate for the treatment of obesity and other cardio-metabolic diseases. In head-to-head non-human primate studies, ASC37 demonstrated an average observed half-life of approximately 17 days—seven times longer than retatrutide—supporting its potential as a once-monthly subcutaneous treatment. In vitro studies showed ASC37 to be 5-, 4-, and 4-fold more potent for GLP-1R, GIPR, and GCGR, respectively, compared to retatrutide. Ascletis expects to submit an Investigational New Drug Application  to the U.S. FDA for ASC37 injection in the second quarter of 2026. These research results have been announced by the company, but have not yet been presented at a scientific meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL5f9lyN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}